NCT02439112
- Conditions
- Behavior, Blood Protein Disorders, Bone Diseases, +20 more
- Locations
-
- Odense University Hospital Odense, Denmark
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,009 public trials
2,034 recruiting studies
Immunoproliferative Disorders trial results
NCT01237236
- Conditions
- Advanced Solid Tumor, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
- Locations
-
- Dana Farber Cancer Institute DFCI Boston, Massachusetts, United States
- University of Michigan Comprehensive Cancer Center SC Ann Arbor, Michigan, United States
- Memorial Sloan Kettering MSKCC (2) New York, United States
- Sarah Cannon Research Institute DeptofSarahCannonRes.Inst. (2) Nashville, Tennessee, United States
NCT01337752
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Female Urogenital Diseases, +19 more
- Locations
-
- University Chicago Hospital Dept. of Univ of Chicago (2) Chicago, Illinois, United States
- Medical Oncology Associates, PS Spokane, Washington, United States
- Novartis Investigative Site Valencia, Spain
- Novartis Investigative Site Madrid, Spain
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Mayo Clinic - Arizona Cancer Clinical Research Unit Scottsdale, Arizona, United States
- Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(3) San Antonio, Texas, United States
- Novartis Investigative Site Melbourne, Australia
- Novartis Investigative Site Frankfurt, Germany
NCT02160951
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Novartis Investigative Site Nagoya, Aichi-ken, Japan
- Novartis Investigative Site Kobe, Hyōgo, Japan
- Novartis Investigative Site Kyoto, Japan
- Novartis Investigative Site Okayama, Okayama-ken, Japan
NCT01456689
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Novartis Investigative Site Chicago, Illinois, United States
- Novartis Investigative Site Ann Arbor, Michigan, United States
- Novartis Investigative Site Rochester, Minnesota, United States
- Novartis Investigative Site Houston, Texas, United States
NCT01956695
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Centre Léon Bérard Lyon, Auvergne-Rhône-Alpes, France
- CHU Estaing Clermont-Ferrand, Auvergne, France
- CHU Bretonneau - Centre Henry Kaplan Tours, Centre-Val de Loire, France
- Institut Bergonié Bordeaux, Gironde, France
NCT02253420
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Dallas, Texas, United States
- Edmonton, Alberta, Canada
- Vancouver, British Columbia, Canada
- Hamilton, Ontario, Canada
NCT04160442
- Conditions
- Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- University of Alabama Birmingham Birmingham, Alabama, United States
NCT00005797
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +52 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States